What You Should Know:
- The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance.
- The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.
- Digital diabetes solutions have disrupted the
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Highmark Taps Lark Health for AI-Driven Chronic Disease Management/Prevention
What
You Should Know:
-
Highmark, one of the largest Blues plans, has chosen Lark Health for its
chronic disease prevention and management platform.
-
Members will have access to Lark’s 24/7 AI-based coaching and programs to
manage diabetes, hypertension, and prevent chronic conditions.
Highmark Inc., America's fourth-largest overall Blue Cross Blue Shield-affiliated organization, announced a growing collaboration with Lark Health, virtual chronic disease prevention and management
Read More
Intermountain Adds Omada’s Diabetes Prevention Program to At-Risk Patients
What You Should Know:
- Omada’s diabetes prevention program will be available
to Intermountain’s at-risk patient population as part of a limited engagement
in 2020 and 2021.
- Omada’s diabetes prevention program is personalized to
meet each participant’s unique needs as they evolve, ranging from diabetes
prevention, type 2 diabetes management, hypertension, behavioral health, and
musculoskeletal issues.
Deepening a collaboration that began in 2016, Omada
Read More
GuideWell to Offer Livongo for Diabetes to Florida Blue Members
What You Should Know:
- GuideWell partners with Livongo to provide Florida Blue
Members an end-to-end consumer-centric virtual care experience.
- Florida Blue will become one of the first health plans to provide health consumers with a single access point for whole-person care through Livongo and Teladoc’s best-in-class combined care experience.
Livongo,
the leading Applied Health Signals company empowering people with chronic
conditions to live better and healthier lives, today
Read More
Virta Adds Prediabetes and Obesity Reversal to Services
What You Should Know:
- Virta is expanding its suite of treatment options to
include prediabetes reversal, obesity reversal, and type 2 diabetes management.
- By making this crucial expansion, Virta can scale its
treatment to support the tens of millions of additional patients with
prediabetes and obesity, as provide an on-ramp to reversal for those with T2D
that aren’t yet ready to reverse.
Virta Health, the
leader in type 2 diabetes reversal, today introduced the addition
Read More
NIH Funds First Nationwide Rare and Atypical Diabetes Network
What You Should Know:
- NIH awards funding for Rare and Atypical Diabetes
Network, or RADIANT that will seek to discover the cause of
several unusual forms of diabetes.
- RADIANT plans to screen about 2,000 people with unknown
or atypical forms of diabetes that do not fit the common features of type 1 and
type 2 diabetes.
The National Institute of
Health (NIH), announced this week it is funding a nationwide study with The Rare and Atypical Diabetes
Network (RADIANT) that will seek
Read More
Is Glucometrics The Missing Data in the Fight Against COVID-19?
Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients.
Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery.
The U.S. health system lacks
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring
What You Should Know:
- Ascensia Diabetes Care and VisiQuate announced a
partnership to expand beyond blood glucose monitoring and provide holistic
diabetes management solutions.
- The overall solution will provide integration with
Ascensia’s existing devices and digital diabetes solutions to enable it to
capture data from patients who have consented to provide their information.
Ascensia Diabetes Care,
a Santa Rosa, CA-based provider of blood glucose monitoring systems
Read More
FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes
What You Should Know:
- Medtronic announced the U.S. Food and
Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump
system with smartphone connectivity and an expanded age indication to patients
with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for
an automated insulin pump system.
- The new
MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app
(compatible with both iPhone and Android), and Roche Accu-Chek®
Read More
